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Edited by Horst FeldmannAbstract In the yeast Saccharomyces cerevisiae the genes in-
volved in galactose metabolism (GAL1,7,10) are transcription-
ally activated more than a 1000-fold in the presence of
galactose as the sole carbon source in the culture media. In the
present work, we monitored the activity of the GAL10 gene pro-
moter in diﬀerent Ras-cAMP genetic backgrounds. We demon-
strate that overexpression of C-terminus of the nucleotide
exchange factor Cdc25p stimulates GAL10 transcription in
yeast strains carrying the contemporary deletion of both RAS
genes. Moreover, the deletion of the chromosomal CDC25 gene
provokes impaired growth on galactose based media in yeast
strain lacking both RAS genes and adenylate cyclase (whose
viability is assured by the presence of the Bcy1-11 allele). Sur-
prisingly, reconstitution of the Ras-pathway inhibits GAL10-
promoter activation. Activation of GAL10 gene promoter is
indeed possible in the presence of Ras protein but only in strains
with chromosomal deletion of adenylate cyclase. These results
indicate a dual role of Ras-pathway on galactose metabolism
and suggest that Cdc25p has a Ras-independent role in cellular
metabolism.
 2007 Federation of European Biochemical Societies. Published
by Elsevier B.V. All rights reserved.
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kinase A1. Introduction
The Leloir pathway is the main enzymatic pathway for the
conversion of galactose to glucose in organisms philogeneti-
cally distant as Escherichia coli and humans [1]. This conver-
sion is mainly realized by three enzymes codiﬁed by genes
collectively referred to as GAL genes in yeast: galactokinase
(EC 2.7.1.6, GALK) corresponding to GAL1 in yeast, phos-
phorylates intracellular galactose to galactose-1-phosphate;
galactose-1-phosphate uridyltransferase (EC 2.7.7.12 GALT),
corresponding to GAL7, transfers UMP from UDP-glucose
to gal-1P forming UDP-gal, and, ﬁnally, UDP galactose 4 0-
epimerase (EC 5.1.3.2, GALE), whose yeast counterpart is
GAL10, converts UDP-gal to UDP-glc, via a NAD+ depen-
dent reaction [2].Abbreviations: PKA, protein kinase A; ATCC, American type culture
collection; PAH, phenylalanine hydroxylase; RT-PCR, reverse trans-
criptase-polymerase chain reaction
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doi:10.1016/j.febslet.2007.04.018Yeast cells respond to the presence of galactose as the sole
carbon source with a several 1000-fold increase of the GAL
genes expression [1–3]. These genes undergo a dual transcrip-
tional regulation. They are repressed in the presence of glucose
and activated in response to galactose [4]. Several experiments
have demonstrated that activation and repression of the GAL
genes act via independent pathways [5–7]. The major transcrip-
tional activator of the GAL genes is the transcription factor
Gal4p [8]. Gal4p is in turn subjected to two levels of regula-
tion. It responds to the presence of intracellular galactose by
4–5-fold increase of its transcriptional level [6,8,9], and by
post-translational modiﬁcation of its interaction with the
repressor Gal80p [10].
Many studies, in yeasts, have related the c-AMP-PKA path-
way to diauxic shift [11–14]. Genetic manipulations of the Ras-
cAMP pathway often result in galactose deﬁcient phenotypes.
Yeast strains expressing an hyperactivated RAS2 allele
(RAS2G19V) show growth impairment on galactose-based
media [15]. Furthermore, in strains with an activated allele
of the adenylate cyclase (CYR1T1651I), contemporary dele-
tions of both RAS genes or deletion of RAS1 combined with
the presence of an attenuated RAS2 allele result in tempera-
ture-sensitive phenotype in galactose [16]. The Ras pathway
has been demonstrated to be positively aﬀected by two diﬀer-
ent nucleotide exchange factors: the essential Cdc25p and the
non essential Sdc25p [17,18]. The overexpression of the former
provokes growth inhibition in galactose [19] and enhanced
transcription of the GAL4 gene [20]. Cdc25p has also been
demonstrated to be essential for growth in galactose-based
media [21]. We investigated the role of CDC25 and RAS2 gene
products in galactose metabolism, monitoring the activity of
the GAL10 gene promoter fused to human phenylalanine
hydroxylase cDNA used as a reporter gene. This reporter
was expressed in various yeast strains diﬀering for the
Cdc25p-Ras-cAMP pathway and the resulting activity of the
GAL10 promoter measured.2. Materials and methods
2.1. Media and yeast manipulation
YPD was used as rich medium (2% bacto peptone, 1% yeast extract
and 2% glucose). Selective synthetic media were prepared with yeast
nitrogen base without aminoacid at 0.67% ﬁnal concentration, with
the appropriate mixture of aminoacids and nucleic acid bases at the
concentration indicated by Sherman [22], with glucose at 2% ﬁnal con-
centration. Standard media containing carbon source diﬀerent from
glucose were obtained with 2% galactose in place of glucose. Genetic
manipulation of yeasts were as described by Mortimer and Schild
[23]. Yeasts transformations were carried out as described by Ito
[24]. All components of media were from DIFCO (Becton Dickinson,
CA, USA).blished by Elsevier B.V. All rights reserved.
2010 M.G. Mirisola et al. / FEBS Letters 581 (2007) 2009–2016Standard molecular biology methods have been performed as indi-
cated by Sambrook et al. [25].List of strains
AAT3B a ade2 can1-100 CRI4 his3 leu2-3,112 lys1-1 ras1D
ras2::URA3 ura3-52
Mirisola et al. [16]
AAT3BD1 a ade2 can1-100 cdc25::LEU2 CRI4 his3 leu2-3,112
lys1-1 ras1D ras2::URA3 ura3-52
Mirisola et al. [16]
ABH7C a ade2 bcy1-11 can1-100 cyr1::HIS3-D1 his3 leu2-3,
112 Lys1-1 ras1D ras2::URA3 ura3-52
Mirisola et al. [16]
ABH7CD1 a ade2 bcy1-11 can1-100 cdc25::LEU2 cyr1::HIS3-D1 his3
leu2-3, 112 Lys1-1 ras1D ras2::URA3 ura3-52
This work
ras1D allele with ras1 deletion without any marker was obtained after gene conversion of the Ras1::URA3
allele in the presence of the plasmid Yep13Hras1D and selection with 5-FOA as described by Mirisola et al.
[16]WOF6.1 (ras1Dras2Dcyr1::URA3 bcy1-11) strain was obtained
transforming the ras1Dras2Dcyr1::HIS3 bcy1-11 (ABE2A, Verrotti
et al., 1992) strain with the EcoRI/BamHI fragment of the pWOF6
vector (Fasano O. unpublished).2.2. PAH reporter construction
The 1.8 kb SmaI/HpaI fragment of the American type culture collec-
tion (ATCC) clone ATCC 61604, containing the entire coding region
of the human phenylalanine hydroxylase (PAH) has been cloned into
the unique SalI restriction site of the YEp51 yeast shuttle vector
[26], after Klenow treatment to ﬁll it in. The proper orientation of
the insert has been veriﬁed by restriction analysis and joint ends have
been veriﬁed by sequencing.2.3. RNA preparation
The desired yeast strain was grown at 30 C, on the appropriate
selective glucose-based medium, to OD560nm = 0.8/1. Cells were col-
lected by centrifugation and resuspended in the same medium, except
for induced cultures, where galactose replaced glucose at the same con-
centration, and cultured at 30 C for additional 24 h. After centrifuga-
tion, the pellet, resuspended in acetate buﬀer (50 mM sodium acetate,
10 mM EDTA, pH 5), was vortexed for 5 0 at 65 C in the presence of
one volume of acid-washed glass beads (SIGMA G-1277, Milano,
Italy) and one volume of phenol pH 5. The aqueous phase was ex-
tracted twice with chloroform and RNA was ﬁnally precipitated with
2.5 V of absolute ethanol, 0.3 M sodium acetate, pH 5.5. After centri-Primer name:
hPAH-RT
hPAH probe For
hPAH probe Rev
GAL4-RT
GAL4-For
GAL4-Rev
GAL80-For
GAL80-Rev
GAL80-RT
CAP-For
CAP-Rev
CAP-RT
Cdc25-RT
Cdc25-For
Cdc25-Rev
TYR1-RT
TYR1-For
TYR1-Revfugation, the pellet was resuspended in TE 10:1. The RNA quality was
veriﬁed evaluating the ribosomal RNA appearance after gel electro-phoresis in denaturing conditions. Poly (A)+ RNA was obtained using
a commercially available kit (QuickPrep Micro mRNA Puriﬁcation
Kit, Amersham, Milano, Italy), according to the manufacturer’s
instruction.2.4. RT-PCR
Poly (A)+ (1 lg) or total RNA, obtained as described above from the
indicated yeast strain, was subjected to retro transcription in the pres-
ence of the RT primer indicated below in the presence of 1 ll of the
Improm (Promega, Madison, WI, USA) reverse transcriptase at
42 C for 1 h, according to the manufacturer’s instructions. Diﬀerent
amounts of each cDNA were used for the subsequent PCR. The prim-
ers for the each PCR are indicated as For and Rev primers. PCR con-
ditions for hPAH; GAL4; GAL80 were as follow: 94 C 3000; 51 C 3000,
72 C 4500 for two cycles and 94 C 3000 60 C 3000 72 C 4500 for addi-
tional 28 cycles. PCR conditions for CAP were 94 C 3000 51 C 3000
72 C 1 01500 for 30 cycles. PCR conditions for CDC25 were 94 C 3000
58 C 3000 72 C 1 0 for 30 cycles. PCR conditions for TYR1 were
94 C 3000 54 C 3000 72 C 1 03000 for 30 cycles.2.5. Northern blot hybridisation
Total RNA (10 lg) were fractionated in a 1.0% agarose–formalde-
hyde gel and blotted onto nitrocellulose membrane (Schleicher & Schu-
ell, PROTRAN BA 83, Dassel, Germany), via capillary action as
described by Sambrook [25]. Filters were baked at 80 C for 2 h under
vacuum. RNA blots were prehybridized with prehybridization buﬀerDNA sequence 50 ﬁ 3 0
gagggcactgcaaaggattcc
aaacctgacccacattgaatctagacc
tgccccatgttttcttttcttcctc
ccctgtagtgattccaaacg
gcggggtttttcagtatctacga
gssgcaagcctgaaagatga
tccttgccgaccagcgtatac
gcatgcacgaaaaagggaaat
gcatgcacgaaaaagggaaat
cgcggtcgacatatgcctgactctaagtacaca
cgcggatccaagcttacacatgaaaaaaaccttt
cgcggatccaagcttacacatgaaaaaaaccttt
ttgcgattttagtcctcttgctg
tggcgggacaaaagaggcactgat
cgtcacggatcgcaacagctctcta
gcctaatattataggaaatcagcatt
gaaggaaagaggacagcatatcca
gcctaatattataggaaatcagcatt
Fig. 1. Expression of the reporter construct YEp51-PAH. Western
blot of whole protein extracts from the AAT3B strain (see the list of
M.G. Mirisola et al. / FEBS Letters 581 (2007) 2009–2016 2011(0.5 M Na2HPO4, pH 7.2, 7% SDS, 1 mM EDTA) at 65 C for 2 h.
The ﬁlters were then hybridized consecutively with random primer-
labelled human PAH cDNA probes (Readyprime Kit, Amersham).
After hybridisation, RNA ﬁlters were washed for 30 min with 50 ml
of 40 mM Na2HPO4 pH 7.2, 1% SDS at 65 C. The ﬁlters were blotted
dry and exposed to X-ray ﬁlm (X-OMAT, Eastman Kodak, Rochester,
NY, USA) for 24–48 h at 80 C.
2.6. Western blotting and immunodetection
Western blot of the human PAH protein has been performed as
described by Mirisola et al. [27].
Western blot of Cdc25p has been performed using a 1:200 dilution of
a commercially available anti Cdc25p antibody (Cdc25 (yC-19):
sc-6761, Santa Cruz Biotechnology, CA, USA).
Western blot of Ras2p has been done using a polyclonal antibody
obtained as described by De Vendittis et al. [45] following the proce-
dure previously described.strains for relevant genotype), transformed with the reporter construct
YEp51-PAH (lane 2) expressing the human PAH under the control of
the GAL10 gene promoter, or with the empty vector (lane 1). Blots
were immunostained with anti-PAH antibodies. Both strains were
galactose-induced as described in Section 2. Puriﬁed maltose binding
protein-PAH fusion protein has been used as positive control (lane 3).
Protein content of each extract was determined by Bradford assay.3. Results and discussion
3.1. Constructing the reporter plasmid
The coding sequence of the human phenylalanine hydroxy-
lase gene (hPAH) has been cloned under the control of the
GAL10 gene promoter of the shuttle vector YEp51 [26] to gen-
erate the reporter plasmid YEp51-PAH (for details, see Section
2).
The use of human PAH gene as a reporter has various
advantages. PAH protein, normally expressed in mammalian
liver cells, is a key enzyme in the production of tyrosine by
means of phenylalanine hydroxylation [28]. Yeast cells pro-
duce tyrosine throughout a pathway that does not involve
any hydroxylating reaction [29]. In addition, BLAST analysis,
even querying with the otherwise conserved PAH catalytic do-
main alone, revealed no signiﬁcant homology between PAH
sequence and the whole yeast genome. These two features
guarantees minimal interference of reporter expression on phe-
notype analysis and virtually no cross-hybridisation eﬀect in
Northern or reverse transcriptase-polymerase chain reaction
(RT-PCR) experiments.
Western blot using a commercial monoclonal antibody
raised against PAH (PH8) of crude protein extracts conﬁrmed
the ability of the reporter to drive the expression of human
PAH (Fig. 1). The in vivo neutrality of the PAH gene expres-
sion was conﬁrmed in various genetic backgrounds (results not
shown) and in diﬀerent growth conditions.
3.2. Eﬀect of the CDC25 gene overexpression on GAL10
promoter activity
A positive relationship between CDC25 gene overexpression
and GAL genes transcriptional derepression has been previ-
ously reported [20,21]. We tested if Cdc25p acts on galactose
metabolism via its well established role as nucleotide exchange
factor (GEF) of the Ras proteins [30,17] or by an unknown
pathway. Full length CDC25 gene (pIND25-2H) or a trun-
cated, but still in vivo active, C-terminus form (AA. 907–
1589, pIND25-1H, [19]) were overexpressed in a recipient yeast
strain lacking both RAS genes (AAT3B; for the relevant geno-
type, see Section 2). It is known that deletion of both RAS
genes is lethal in yeast [31]. We overcame this problem using
a mutated allele of the adenylate cyclase gene (CYR1T1651I),
which is able to produce a basal level of cAMP even in the ab-
sence of any Ras protein [32,16] but it is still sensitive to Ras
function [16]. Competent cells of this recipient yeast strain,expressing episomal reporter PAH gene under the control of
the yeast GAL10 gene promoter (YEp51-PAH) were trans-
formed with CDC25 expression plasmids, either full length
or C-terminus (pIND25-2H and pIND25-1H, respectively) or
with the empty vector. Total RNA extracted from selected
transformants grown on galactose, as described in Section 2,
were analysed by RT-PCR, using PAH-speciﬁc oligonucleo-
tides. We demonstrate that in the absence of both RAS genes,
overexpression of the truncated form of Cdc25p is capable to
activate the GAL10-dependent transcription of the PAH re-
porter gene (Fig. 2a) while full length Cdc25p has only a mar-
ginal eﬀect. The diﬀerent activity between full length and
truncated version of Cdc25p can be explained by the diﬀerent
amount of the two proteins. Only the truncated form of
Cdc25p can be eﬃciently overexpressed [20]. It has been dem-
onstrated that full length Cdc25p, compared to its truncated
version, has a reduced stability [34] probably caused by the
presence of a cyclin disruption box in its N-terminus moiety
[44].
To further conﬁrm that C-terminus of Cdc25p is capable to
activate GAL10-driven transcription we performed Northern
blot analysis of poly (A)+ RNA extracted from the same yeast
strains with or without the overexpression of the truncated
Cdc25p. Radioactively labelled PAH coding sequence has been
used as a probe in stringent hybridisation conditions (for de-
tails, see Section 2). A strong enhancement of the PAH-speciﬁc
hybridisation signal resulted in the presence of Cdc25 overex-
pression (Fig. 2b). In addition, whole protein extracts (for de-
tails, see Section 2) from the same yeast strains grown in the
same conditions were subjected, after SDS–PAGE fraction-
ation, to immunoblot with a commercial anti-PAH antibody
(PH8). We conﬁrmed (Fig. 2c) the ability of the C-terminus
of Cdc25p nucleotide exchange factor to stimulate GAL10-
dependent transcriptional activity. This result clearly indicates,
for the ﬁrst time, that Cdc25p has a Ras-independent role on
galactose metabolism. Since GAL genes are normally activated
by a 4–5-fold transcriptional increasing of GAL4 mRNA
[6,8,9] we measured the mRNA level of GAL4 and GAL80 in
the presence and in the absence of C-terminus Cdc25p. Total
RNA from strains lacking both RAS genes and overexpressing
Fig. 2. Eﬀect of full length or C-terminus Cdc25 overexpression in a
strain lacking both RAS genes. (a) Reporter RT-PCR Upper panel:
RT-PCR of PAH mRNA in the presence of C-terminus (AA. 907–
1589, lanes: 1 and 2); full length (lanes 3 and 4) or without episomal
CDC25 (lanes 5 and 6). Diﬀerent dilution of PAH cDNA were used for
subsequent PCR: 1 ll (lanes: 1, 3, and 5); 0.1 ll (lanes: 2, 4, and 6). RT-
PCR of CAP mRNA in the presence of C-terminus (lane 7); full length
(lane 8) or absence (lane 9) of Cdc25p overexpression was used as a
control. Amount and quality of RNA used were determined by
electrophoresis of ribosomal RNA (not shown). Lower panel: densi-
tometric analysis of upper panel. The results are the average of three
independent experiments. (b) Northern blot. Autoradiography of 1 lg
poly (A)+ RNA extracted from AAT3B (see list of strains for relevant
genotype) yeast strain cotrasformed with YEp51-PAH and C-terminus
Cdc25 (lane 1), with YEp51-PAH and YEp13H (lane 2) were
fractionated in denaturing conditions, blotted and hybridised in
stringent conditions with a radioactively labelled PAH speciﬁc probe
(for details see Section 2). (c) Western blot Immunostaining of PAH
protein on Western blot obtained after SDS–PAGE fractionation of
whole protein extract from the AAT3B strain overexpressing (lane 2),
or not expressing (lane 1) the carboxy-terminus (AA. 907–1589) of the
Cdc25 protein. Protein content of each extract was normalized by
Bradford assay.
2012 M.G. Mirisola et al. / FEBS Letters 581 (2007) 2009–2016the truncated form of Cdc25p or the corresponding empty vec-
tor have been subjected to RT-PCR using oligonucleotidesspeciﬁc for GAL4 and GAL80 RNAs. From this experiment
GAL4 transcript level results almost doubled in the presence
of Cdc25p while GAL80-speciﬁc RNA appears unaﬀected
(Fig. 3). This suggests that the Cdc25-dependent activation
mechanism of GAL genes acts, directly or indirectly, enhancing
the transcription and/or mRNA stability of the GAL4 gene.
Van Aelst and coworkers have previously demonstrated that
Cdc25p overexpression abolishes glucose repression of invert-
ase activity in yeast cells [47]. Unfortunately, the plasmids we
have used to overexpress Cdc25p are under the control of the
GAL10 gene promoter limiting the possibility to observe the
role of Cdc25p on glucose-based media. It would be interesting
to overexpress Cdc25p under the control of a diﬀerent gene
promoter to see if Cdc25p is capable to relief glucose repres-
sion of GAL genes expression both with and without the pres-
ence of RAS function.
The possibility of physical interaction of Cdc25p with pro-
teins other than Ras has been suggested several times. Fras-
cotti and colleagues [19] suggested a Cdc25-dependent
stimulation of a GTPase, other than Ras proteins, with a role
in galactose metabolism. Physical interaction and modulation
between Cdc25p and chaperones has been detected [33] and
a role of Cdc25p on stress response in a cAMP-independent
pathway has been postulated [34]. In addition several
CDC25-interactors have been identiﬁed by two hybrid screens.
Further studies will be necessary to identify which protein of
the galactose metabolism Cdc25p interacts to.
It must be noted that the truncated version of Cdc25p used
in this study contains a domain (AA. 907–1589) of the Cdc25p,
suﬃcient to enhance dissociation of the nucleotide bound to
Ras protein [35]. For this reason, it is likely that this Ras-inde-
pendent role of Cdc25p in galactose metabolism is due to its
ability to enhance the nucleotide exchange of a diﬀerent
GTP binding protein rather than to an undiscovered biochem-
ical function of the Cdc25p.
3.3. Phenotype of CDC25 gene deletion in strains lacking
adenylate ciclase and/or both RAS genes
The chromosomal CDC25 gene disruption is normally lethal
[30,36]. Herein, we evaluated the eﬀect of the same gene dele-
tion in strains lacking both RAS genes (AAT3B) or lacking
both RAS genes and adenylate cyclase (ABH7C). The suppres-
sion of the lethality by an allele of the adenylate cyclase in the
strain AAT3B is discussed in the previous paragraph. The
lethality of the contemporary deletion of both RAS genes
and/or adenylate cyclase (ABH7C) can be rescued by the pres-
ence of the bcy1-11 allele which allows suﬃcient kinase A
activity, even in the absence of adenylate cyclase [37]. The
AAT3B and ABH7C strain (for the relevant genotype, see Sec-
tion 2) were engineered by replacing the CDC25 gene with a
disrupted cdc25::LEU2 allele, using the disruption plasmid
and procedure described by Baroni et al. [38], thus generating
the AAT3BD1 and ABH7CD1 strains, respectively. Selected
transformants were individually analysed by replica plating
on diﬀerent carbon sources at diﬀerent temperatures of incuba-
tion. The results shown in Table 1 indicate that deletion of
CDC25 in strain lacking both RAS genes (AAT3B) displays
no phenotype while the same gene disruption in a strain
(ABH7C) lacking both RAS genes and adenylate cyclase is al-
ways associated with an impaired growth on glycerol based
media at 30 and 37 C and on galactose based media at
37 C for all colonies tested (Table 1 and Fig. 4). More exper-
Fig. 3. Eﬀect of Cdc25 overexpression on GAL4 and GAL80 mRNA level. Upper panel: RT-PCR of GAL4 mRNA (lanes 1–4) or GAL80 mRNA
(lanes 5 and 6) were performed in the absence (lanes: 1, 2, and 5) or presence (lanes: 3,4, and 6) of Cdc25p carboxy-terminus (AA. 907–1589)
overexpression. Diﬀerent dilution of cDNA were used for subsequent PCR: 1 ll (lanes: 1, 3, 5, and 6); 0.1 ll (lanes: 2 and 4). Lower panel:
densitometric analysis of upper panel. The results are the average of three independent experiments.
Table 1
Phenotypes have been judged after three days of growth
YPD YPGly YPGal
30 C 37 C 30 C 37 C 30 C 37 C
AAT3B + + +  + +/
AAT3BD1 + + +  + +/
ABH7C + + +  + +/
ABH7CD1 + +   + 
Fig. 4. Phenotypic eﬀect of CDC25 deletion in a strain lacking both
RAS genes. Replica plating of patches deriving from individual
colonies of the ABH7C yeast strain carrying a wild type (ﬁrst two
patches) or a disrupted (the remaining 31 patches) allele of CDC25
(cdc25::LEU2, ABH7CD1) in glucose and galactose based media.
Plates were incubated at 37 C and analysed after 72 h.
M.G. Mirisola et al. / FEBS Letters 581 (2007) 2009–2016 2013iments would be necessary to discriminate if the diﬀerent sen-
sitivity of the two yeast strains to the CDC25 gene deletion is
due to the presence/absence of the adenylate cyclase or to
unidentiﬁed diﬀerences between the two yeast strains. How-
ever, the response to nutrients of yeast cells has been demon-
strated to be modulated by Ras proteins and more recently
by the Ga Gpa2 [39,40]. This latter protein has also been dem-
onstrated to act in a Ras independent pathway [41] responding
to extracellular nutrients [40]. Furthermore, in the ﬁssion yeast
a direct interaction of Gpa2 with adenylate cyclase has been
assessed [42,43]. It is therefore possible that the deletion of
adenylate cyclase in the ABH7C strain abolishes both Ras
dependent and Gpa2p dependent activation of adenylate cy-
clase resulting in the observed enhanced sensitivity to
CDC25 gene deletion. It is interesting to note that while the
phenotype resulting from the episomal expression of C-termi-
nus Cdc25p may be due to non physiological interaction be-
tween the overexpressed Cdc25p and an unknown protein,
the phenotype resulting from the chromosomal deletion ofCDC25 in a strain lacking both RAS genes and adenylate
cyclase implies a physiological role of this exchange factor in
galactose metabolism via a Ras-cAMP-independent pathway.
3.4. GAL10 promoter activity and RAS2 function
To further characterize the role of Ras pathway in galactose
metabolism, wild type RAS2 or attenuated RAS2R80DN81D
alleles were re-introduced by homologous recombination [16]
in a strain containing the PAH reporter plasmid and over-
expressing the C-terminus of the Cdc25 protein. RT-PCR were
performed using PAH-speciﬁc oligonucleotides in total RNA
fractions extracted from glucose or galactose grown cells.
Fig. 6. RT-PCR analysis of CDC25mRNA in the presence of diﬀerent
RAS2 alleles. Upper panel: RT-PCR of CDC25 in a strain lacking
both RAS2 and C-terminus CDC25 (AAT3B YEp13H, lane 1), lacking
RAS2 but in the presence of C-terminus CDC25 (AAT3B pIND25-1H,
lane 2), in the presence of wild type RAS2 and C-terminus CDC25
(AAT3BR2 pIND25-1H, lane 3), in the presence of an mutated RAS2
allele and C-terminus CDC25 (AAT3B R2 D80D81 pIND25-1H, lane
4) and in the absence of RAS2 in the presence of C-terminus CDC25
but in the absence of chromosomal CDC25 (AAT3B Dcdc25 PIND25-
1H, lane 5). Lower panel: RT-PCR of total RNA extracted from the
same yeast strains of the upper panel using oligonucleotides and
2014 M.G. Mirisola et al. / FEBS Letters 581 (2007) 2009–2016Surprisingly the RAS2 re-introduction completely abolishes
the Cdc25-dependent activation of GAL10 promoter (result
not shown). To shed a light on this Ras-dependent eﬀect we
measured the amount of exchange factor protein Cdc25p by
immunoblot in diﬀerent yeast strains. Whole protein extracts
from strains expressing RAS2 wild type, RAS2R80DN81D or
the null allele in combination with C-terminus Cdc25p were
subjected to SDS–PAGE and immunostained with a commer-
cial anti-Cdc25p antibody (see Section 2 for details). The result
shown in Fig. 5 indicates that the amount of Cdc25p strongly
decreases in the presence of a wild type RAS2 allele compared
to strains expressing a ras2 null allele or a ras2-attenuated al-
lele (RAS2R80DN81D). To discriminate if Ras2p exerts its ac-
tion on the expression of the truncated form of Cdc25 at
transcriptional or posttranscriptional level we performed RT-
PCR using Cdc25-speciﬁc oligonucleotides on total RNA ex-
tracts from strains containing wild type, attenuated or null
RAS2 alleles. CDC25 mRNA level, as judged by RT-PCR
(Fig. 6), strongly decreases in the presence of active Ras2p
while it is unaﬀected by the presence of attenuated Ras2p
(Ras2R80DN81D). Since the episomal expression of both
PAH and CDC25 (pIND25-1H) is under the control of the
GAL10 gene promoter these results indicate that reintroduc-
tion of wild type RAS2 inhibits the transcription of GALgenes
while reintroduction of the attenuated allele of RAS2
(RAS2R80DN81D) has no eﬀect.
We further studied if the inhibitory role of Ras2p reintro-
duction on GAL10 promoter activity was due to the presence
of Ras2p itself or to the activation of the adenylate cyclase.
Yeast strain lacking both adenylate cyclase and RAS genes
(WOF6.1) was used as a recipient strain to express wild type
and activated (G19V) Ras2 proteins under the control of the
GAL10 gene promoter of the YEp51 high copy number shuttleFig. 5. Quantiﬁcation of Cdc25p in the presence of diﬀerent RAS2
alleles. (a) Immunostaining of Cdc25 protein on Western blot obtained
after SDS–PAGE of whole protein extract from a strain lacking both
RAS2 and C-terminus CDC25 (AAT3B YEp13H, lane 1), lacking
RAS2 but in the presence of C-terminus CDC25 (AAT3B pIND25-1H,
lane2), in the presence of wild type RAS2 and C-terminus CDC25
(AAT3BR2 pIND25-1H, lane 3), in the presence of an mutated RAS2
allele and C-terminus CDC25 (AAT3B R2 D80D81 pIND25-1H, lane
4) and in the absence of RAS2 in the presence of C-terminus CDC25
but in the absence of chromosomal CDC25 (AAT3B Dcdc25 PIND25-
1H, lane 5). (b) Red Poinceau staining of the same ﬁlter before
immunostaining.
reaction conditions speciﬁc for TYR1 gene.vector (see Section 2 for details). Recombinant clones were
transformed with an expression vector of the adenylate cyclase
(YACW, [46]) or with the corresponding empty vector. Total
protein extracts from individual clones, after SDS–PAGE,
were immunoblotted with a polyclonal anti-Ras antibody
(see Section 2) conﬁrming (Fig. 7) the possibility to overex-
press both wild type and mutated forms of Ras2 protein.
Adenylate cyclase reintroduction strongly diminished the
amount of both wild type and activated Ras2 protein as judgedFig. 7. Quantiﬁcation of Ras2 protein in the presence/absence of the
adenylate cyclase. Immunostaining of Ras2 protein on Western blot
obtained after SDS–PAGE of whole protein extract of yeast strains
grown on galactose and episomally expressing under the control of
GAL10 promoter Ras2 wild type (WOF6.1-Yep51-R2, lanes 3 and 4)
or Ras2G19V (WOF6.1-Yep51-R2V19 lanes 5 and 6) in the absence
(Yep13H, lanes 3 and 5) or in the presence (YACW lanes 4 and 6) of
episomally encoded adenylate cyclase. An yeast strain lacking both
RAS genes (ABH7C, lane 1) and an yeast strain (19D, lane 2) with a
wild type chromosomal copy of RAS2 were used as a control.
M.G. Mirisola et al. / FEBS Letters 581 (2007) 2009–2016 2015by immunoblot. These results indicate that reconstitution of
the Ras pathway inhibits GAL10 driven transcription and that
this inhibition is dependent upon activation of the Ras-cAMP-
PKA pathway and not by the presence of Ras2 protein itself.
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